The content on this site is intended for healthcare professionals only
Dr Raghavan Vidya speaks to ecancer in an online interview about the question, 'should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic?'.
She explains how the COVID-19 pandemic has impacted breast cancer patients, including how treatment has been affected.
Dr Vidya also introduces some short clips of her colleagues and fellow authors from around the world who give a global perspective.
You can read the article published in ecancermedicalscience here.
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 25th - 31st, 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
The advantages of IORT for early breast cancer treatment
Advancing breast cancer diagnosis in the developing world
